Brady M. Bernard, PhD
Earle A. Chiles Research Institute
Providence Cancer Institute
Director, Bioinformatics
Providence Health & Services
Dr. Bernard has a background in bioengineering, with experience in integrative analysis of complex multi-omic datasets in a clinical environment. Currently, he leads the Computational Immuno-Oncology Lab at the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy. He is also the director of bioinformatics at Providence.
Dr. Bernard serves as the lead bioinformatics scientist for Providence in a multi-institutional collaboration led by the American Association for Cancer Research (AACR). AACR’s Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international pan-cancer registry of real-world data assembled through a consortium of leading cancer centers, including Providence Cancer Institute. Its goal is to improve clinical decision-making by aggregating, harmonizing and sharing clinical-grade, next-generation sequencing data obtained during routine medical practice. He also contributed to the Genome Data Analysis Center within The Cancer Genome Atlas (TCGA) network as an integral part of a diverse team of research scientists, bioinformaticians and software engineers.The Computational Immuno-Oncology Lab develops and applies computational approaches to study the relationship between the immune system and cancer. Areas of investigation include therapeutic target discovery and drug development, neoantigen pipeline development in support of clinical adoptive cellular therapy, and integrative analysis of clinical and multi-omic data.
- Postdoctoral, Genomics, Institute for Systems Biology, 2012
- Doctor of Philosophy, Bioengineering & Computational Biology, University of Washington, 2009
- Master of Science, Bioengineering, University of Washington, 2006
- Bachelor of Science, Bioengineering, University of California San Diego, 2001
- Assistant member, Computational Immuno-Oncology Laboratory, Earle A. Chiles Research Institute, Providence Cancer Institute, 2018-present
- Director, Bioinformatics, Providence Health & Services, 2021-present
- Associate director, Bioinformatics Clinical Genomics, Providence Health & Services, 2016-2020
- Senior research scientist, Institute for Systems Biology, 2013-2016
- Research scientist, Institute for Systems Biology, 2012-2013
- Instructor, BIOL 318 Genomics, Seattle University, 2011-2012
- Postdoctoral fellow, Institute for Systems Biology, 2010-2012
- Commercialization associate, Washington Biotechnology & Biomedical Association, 2009
- Project manager and research engineer, Ichor Medical Systems, Inc., 2001-2003
- Project Genomics Evidence Neoplasia Information Exchange (GENIE), American Association for Cancer Research (AACR), 2018-present
- National Science Foundation (NSF) Faculty Institutes for Reforming Science Teaching (FIRST IV) Scholar, 2011-2012
- Genome Data Analysis Center within The Cancer Genome Atlas, 2010-2016
- AACR Team Science Award, 2020
- AACR Scholar-in-Training Awardee, 2015
- YarcData Big Data Graph Analytics Challenge First Prize, 2013
- Venture Capital Fellow, Accelerator Corp., 2010-2011
- Business Plan Competition: Semi-Finalist, University of Washington, 2009
- Venture Capital Investment Competition: Champion, University of Washington; Champion, Silicon Valley Regional (Santa Clara); Finalist, Internationals (University of North Carolina), 2009
- Kauffman Foundation Entrepreneurial Postdoctoral Fellowship Finalist, 2009
- NSF-MRSEC Fellow, University of Washington, 2008-2009
- Early Bird Award in Nanotechnology, University of Washington, 2003
Dr. Bernard’s research is featured in peer-reviewed scientific and medical publications. He has partnered with colleagues on various research projects, such as The Cancer Genome Atlas and Project GENIE.